Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 6.85% |
AMGEN INC. | AMGN | 4.90% |
GILEAD SCIENCES, INC. | GILD | 4.77% |
VERTEX PHARMACEUTICALS | VRTX | 4.69% |
REGENERON PHARMACEUTICALS | REGN | 3.70% |
CORTEVA INC | CTVA | 3.29% |
ALNYLAM PHARMACEUTICALS | ALNY | 2.69% |
BEIGENE LTD ADR | BGNE | 2.42% |
NATERA INC | NTRA | 2.22% |
ASTRAZENECA PLC ADR | AZN | 2.19% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.99% |
BIOGEN IDEC, INC. | BIIB | 1.93% |
UNITED THERAPEUTICS CORP | UTHR | 1.80% |
INSMED INC | INSM | 1.75% |
ILLUMINA INC | ILMN | 1.62% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.59% |
EXELIXIS, INC. | EXEL | 1.55% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.53% |
EXACT SCIENCES | EXAS | 1.50% |
ARGENX SE - ADR | ARGX | 1.46% |
VIATRIS INC | VTRS | 1.39% |
INCYTE CORP | INCY | 1.38% |
BIONTECH SE-ADR | BNTX | 1.35% |
HALOZYME THERAPEUTICS INC | HALO | 1.30% |
MODERNA INC | MRNA | 1.27% |
GUARDANT HEALTH INC | GH | 1.24% |
REVOLUTION MEDICINES INC | RVMD | 1.23% |
BRIDGEBIO PHARMA INC | BBIO | 1.22% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.21% |
ADMA BIOLOGICS INC | ADMA | 1.17% |
TG THERAPEUTICS | TGTX | 1.15% |
BLUEPRINT MEDICI | BPMC | 1.12% |
CRISPR THERAPEUTICS AG | CRSP | 1.11% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.06% |
ALKERMES PLC | ALKS | 1.06% |
ROIVANT SCIENCES LTD | ROIV | 1.06% |
SUMMIT THERAPEUTICS INC | SMMT | 1.02% |
MEDPACE HOLDINGS | MEDP | 0.99% |
IONIS PHARMACEUTICALS, IN | IONS | 0.99% |
CYTOKINETICS INC | CYTK | 0.99% |
SAREPTA THERAPEU | SRPT | 0.92% |
AXSOME THERAPEUT | AXSM | 0.89% |
ULTRAGENYX PHARM | RARE | 0.85% |
AVIDITY BIOSCIENCES INC | RNA | 0.84% |
PTC THERAPEUTICS | PTCT | 0.83% |
CRINETICS PHARMACEUTICALS | CRNX | 0.79% |
VERACYTE INC | VCYT | 0.78% |
SPRINGWORKS THERAPEUTICS | SWTX | 0.78% |
VIKING THERAPEUTICS INC | VKTX | 0.76% |
PROTAGONIST THER | PTGX | 0.75% |
RECURSION PHARMACEUTICALS | RXRX | 0.72% |
ARCELLX INC | ACLX | 0.71% |
ASCENDIS PHA-ADR | ASND | 0.70% |
TWIST BIOSCIENCE CORP | TWST | 0.67% |
DENALI THERAPEUT | DNLI | 0.67% |
VAXCYTE INC | PCVX | 0.65% |
AMICUS THERAPEUTICS INC | FOLD | 0.64% |
IDEAYA BIOSCIENCES INC | IDYA | 0.62% |
NUVALENT INC-A | NUVL | 0.62% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.62% |
BEAM THERAPEUTICS INC | BEAM | 0.60% |
APELLIS PHARMACE | APLS | 0.58% |
AGIOS PHARMACEUT | AGIO | 0.57% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.57% |
MADRIGAL PHARMAC | MDGL | 0.56% |
KRYSTAL BIOTECH INC | KRYS | 0.53% |
CELLDEX THERAPEUTICS INC | CLDX | 0.53% |
DYNAVAX TECHNOLOGY | DVAX | 0.51% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.47% |
DYNE THERAPEUTICS INC | DYN | 0.44% |
IMMUNOVANT INC | IMVT | 0.43% |
NOVAVAX INC | NVAX | 0.43% |
INTELLIA THERAPE | NTLA | 0.43% |
GERON CORP | GERN | 0.28% |
Other (Cash, derivatives and other liabilities) | 0.51% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.